JURIST

AUGUST 17, 2022

Though GSK is one of the primary sellers of Zantac, the drug has also been sold by Pfizer , Boehringer Ingelheim and Sanofi , among other companies. The FDA describes NDMA as a “probable human carcinogen,” which can cause cancer if consumed.

Manufacturing 104

Manufacturing Litigation Litigating Personal Injury 104

SCOTUSBlog

NOVEMBER 13, 2023

She went to court filed a lawsuit in federal court in Alabama against Boehringer Inhelheim Pharmaceuticals, the manufacturer of Zantac, and against Walgreens, which sold the drug, alleging that Zantac caused her cancer. Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc.

Court 91

Court Manufacturing Litigation Litigating 91

FDA Law Blog

MARCH 12, 2024

As we explained in September 2023 , then again in November 2023 , the FTC has intervened in the matter and asked 10 drug companies (really 8 given common ownerships of some of the relevant companies) to delist about 100 patents from the Orange Book that mainly cover the device constituent of a drug/device combination product.

Manufacturing 59

Manufacturing Statute Litigation Litigating 59

FDA Law Blog

OCTOBER 4, 2023

However, Judge Newman distinguished Michigan Bell from the present case because the Michigan law, which compelled participation by the plaintiff telephone companies, denied them of their right to a “fair and reasonable rate of return.” See Motion at 11. Order at 22. See Order at 15, 21.

Manufacturing 59

Manufacturing Litigation Litigating Court 59

Law 360

OCTOBER 3, 2023

Bristol Myers Squibb, Janssen Biotech, AstraZeneca, Boehringer Ingelheim and other pharmaceutical companies have agreed to negotiate with the Biden administration under the Inflation Reduction Act's Medicare drug price negotiation provision, the White House announced Tuesday.

40

40

FDA Law Blog

MARCH 5, 2024

AstraZeneca also claimed that CMS’s revised guidance on the Negotiation Program for Price Applicability Year 2026 (“Guidance”) interpreted the IRA in two very faulty ways, which violated the Administrative Procedure Act (APA) and harmed and will continue to harm the company. and the revenue it derives therefrom. 2023) Jardiance Merck D.D.C.

Court 64

Court Statute Manufacturing Government 64